Advanced Genomic Solutions Real Time Genomics develops cutting-edge analytical platforms for next-generation sequencing technologies, making their offerings highly relevant for labs seeking to improve the accuracy and efficiency of genomic data analysis, especially in personalized medicine and clinical applications.

Cloud and On-Premise Flexibility The company provides flexible deployment options, including cloud-based access and on-site installation, enabling potential clients with diverse infrastructure needs to adopt their solutions seamlessly.

Growing Product Suite The recent launches of RTG Core and associated tools indicate ongoing innovation, presenting opportunities to upsell or expand existing client licenses with the latest analysis capabilities.

Strategic Partnerships Collaborations with biotech firms like TOMA Biosciences to develop clinical-grade analysis tools suggest a focus on expanding into liquid biopsy markets, creating cross-selling opportunities in tumor sequencing and oncology diagnostics.

Funding and Scale With a modest revenue range and recent $5M funding, the company is poised for growth; identifying prospects that need affordable, scalable genomic analysis solutions could position sales teams to target emerging and mid-sized research and clinical organizations.